Evozyne

aid: evozyne
name: Evozyne
description: 'Evozyne is an AI-native protein therapeutics company founded in 2020 by Paragon Biosciences and headquartered
  in Chicago, Illinois. It combines generative machine learning with directed evolution and high-throughput biology to design
  de novo proteins — which it brands Natural Machines — and advance them as engineered protein therapeutics for immune-mediated
  diseases. The platform pairs AI protein design with wet-lab build-and-test cycles, and the company has collaborated with
  NVIDIA on model work and with the Gates Foundation on sustainability applications. Evozyne is a drug-discovery organization
  rather than a software vendor: it publishes a corporate website, a pipeline page, scientific publications and news, but
  no public API, developer portal, SDK or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/evozyne/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://evozyne.com/wp-content/themes/evozyne/markup/dist/images/logo.svg
x-type: company
x-source: harvest:secondary-market
x-source-url: https://forgeglobal.com/evozyne_stock/
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Life Sciences
- Artificial Intelligence
- Protein Design
- Drug Discovery
- Therapeutics
- Immunology
- Machine-Learning
tags_raw:
- Company
- Biotechnology
- Life Sciences
- Artificial Intelligence
- Protein Design
- Drug Discovery
- Therapeutics
- Immunology
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evozyne-domain-security.yml
- type: Website
  url: https://evozyne.com/
- type: GitHubOrganization
  url: https://github.com/Evozyne
- type: TermsOfService
  url: https://evozyne.com/terms-of-use/
- type: PrivacyPolicy
  url: https://evozyne.com/privacy-policy/
- type: News
  url: https://evozyne.com/about-us/news/
- type: Careers
  url: https://evozyne.com/careers/
- type: Contact
  url: https://evozyne.com/contact-us/
- type: Products
  url: https://evozyne.com/platform/
- type: Research
  url: https://evozyne.com/platform/science/
- type: About
  url: https://evozyne.com/about-us/
- type: LLMsTxt
  url: llms/evozyne-llms.txt
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Evozyne is a clinical-stage protein therapeutics company whose product is a drug pipeline rather than software,
    and evozyne.com is a WordPress marketing site where /openapi.json, /graphql and every /.well-known/ path 404 while api.,
    docs. and developer.evozyne.com do not resolve in DNS at all.
  evidence:
  - url: https://evozyne.com/openapi.json
    status: 404
  - url: https://evozyne.com/graphql
    status: 404
  - url: https://evozyne.com/.well-known/agent-card.json
    status: 404
  - url: https://evozyne.com/llms.txt
    status: 404
  - url: https://evozyne.com/
    status: 200
  checked: '2026-08-12'